We have investigated the effects of natriuretic peptides on oscillations in [Ca 2+ 
concentration) in two different cell types: freshly isolated rat hepatocytes and the ECV304 cell line. Our data, from both cell types, suggest that natriuretic peptides modulate the frequency of [Ca 2+ ] c oscillations through alterations in plasma membrane Ca 2+ fluxes. Here, we review evidence for a role for plasma membrane Ca 2+ fluxes in the control of the frequency of [Ca 2+ ] c oscillations. We describe a hypothetical mechanism through which this might be achieved. We propose a physiological role for regulated control of Ca 2+ efflux in modulating [Ca 2+ ] c oscillations.
Oscillations in [Ca 2+ ] c (cytosolic free Ca 2+ concentration) are a fundamental mechanism of intracellular signalling [1] . One of the first direct demonstrations of agonist-induced [Ca 2+ ] c oscillations was made in single, aequorin-injected rat hepatocytes by Woods et al. [2] . These investigators showed that single rat hepatocytes, when stimulated with low physiological concentrations of agonists acting through the phosphoinositide signalling pathway, generated discrete transient increases in [Ca 2+ ] c , rising from a baseline [Ca 2+ ] c similar to that recorded in unstimulated cells. Baseline [Ca 2+ ] c oscillations of this type are observed in many cell types [3] . An important property of baseline [Ca 2+ ] c oscillations is that their frequency is dependent on agonist concentration; raising agonist concentration increases the frequency of [Ca 2+ ] c oscillations [4] [5] [6] . Another common feature of baseline [Ca 2+ ] c oscillations is a phenomenon we term 'agonist specificity' [4, 7] . Within an individual cell, the duration of [Ca 2+ ] c transients generated depends on the stimulating agonist; the variability in transient duration lies in the rate of fall of [Ca 2+ ] c from its peak. For example, in aequorin-injected hepatocytes, the α 1 -adrenergic agonist phenylephrine always induces [Ca 2+ ] c transients of approx. 7 s duration and vasopressin induces transients of approx. 10 s duration [4] , whereas ATP induces transients of up to 90 s duration [7] .
Cytosolic Ca 2+ homoeostasis and signalling is achieved by the complex interplay of Ca 2+ fluxes between the cytosol, intracellular stores and the extracellular environment. More- [5, 18, 21] , depolarized fibroblasts [22] and AR42J cells [23] .
In marked contrast, the role of plasma membrane Ca [24] . We showed that two inhibitors of the PMCA, carboxyeosin [25, 26] and glucagon-(19-29) (also known as mini-glucagon; [27] ) had similar effects on [Ca 2+ ] c oscillations in rat hepatocytes. Ca 2+ efflux from rat hepatocytes occurs via the PMCA; under physiological conditions, NCX does not play a role in this cell type [28] . Both carboxyeosin and mini-glucagon ( Figure 1a) [32, 33] . Our observation that mini-glucagon inhibits Ca 2+ efflux from intact rat hepatocytes and potentiates oscillatory [Ca 2+ ] c signalling in hepatocytes by increasing oscillation frequency (Figure 1a ) [24] demonstrates that this mode of oscillation regulation is highly relevant. Miniglucagon is a physiological agonist for hepatocytes: it is a C-terminal fragment of glucagon, formed on the hepatocyte plasma membrane by the action of a specific endopeptidase [34] . Mini-glucagon, at a concentration of 1 nM, partially inhibits ATP-dependent Ca 2+ uptake in rat liver plasma membrane vesicles [27] . It does not stimulate Ca 2+ release [24] ; nor, unlike native glucagon, does it stimulate adenylate cyclase activity [35] .
More recently, we have identified another group of agents that appear to affect Ca 2+ homoeostasis and oscillations through the manipulation of Ca 2+ efflux. The natriuretic peptides ANP (atrial natriuretic peptide) and BNP (brain natriuretic peptide) are circulating hormones that are generated in the atrium and the brain respectively. Recent work indicates other tissue sources of natriuretic peptides; for example, BNP is produced by cardiac ventricles [36] and ANP is produced in the liver [37] . Although ANP and BNP are well known for their cardiovascular and renal vasodilatory activities, other roles have been identified in non-vascular tissues, such as protection from free radical damage [38] . Pharmacologically, ANP and BNP are very similar, and are ligands for the guanylate cyclase-coupled type A receptor, a plasma membrane-bound receptor possessing intrinsic guanylate cyclase activity.
Our first evidence that ANP could modulate [Ca 2+ ] c responses came from the ECV304 cell line [39] . Here we found that, although BNP had no effect on resting [ [39, 40] . Elevated cGMP has been reported to inhibit Ca 2+ influx into several cell types [41] [42] [43] [44] [45] . Numerous models have been proposed to explain the generation of baseline [Ca 2+ ] c oscillations, many of which are reviewed by Thomas et al. [6] . The models can be broadly classified into two groups: those in which oscillations in InsP 3 (inositol 1,4,5-trisphosphate) levels precede those in [Ca 2+ ] c , and those in which [Ca 2+ ] c oscillations are generated in the absence of oscillatory behaviour of InsP 3 . This field continues to be subject to intense study following the emergence of experimental evidence that InsP 3 levels can oscillate [46, 47] . We have recently proposed a model for [Ca 2+ ] c oscillations in hepatocytes that encompasses an explanation for agonist specificity [48] .
In the two cell types we have studied, rat hepatocytes [24, [40] [41] [42] [43] [44] [45] and the ECV304 cell line [39] , it is apparent that plasma membrane Ca 2+ flux is an important determinant of the frequency of [Ca 2+ ] c oscillations. We have previously described a hypothetical mechanism to explain how plasma membrane Ca 2+ fluxes may influence [Ca 2+ ] c oscillation frequency. This is illustrated in Figure 3 . Our argument is compatible with a number of models, whether they involve InsP 3 receptors, ryanodine receptors, interactions between both release channels, or whether modulators such as InsP 3 are constant or oscillate themselves. The key features of the proposed mechanism are that the [Ca 2+ ] c oscillations originate from a specific initiation site adjacent to the plasma membrane [49] , and that we identify changes in plasma mem- (Figure 3) . There is increasing evidence that frequency modulation of oscillatory [Ca 2+ ] c signalling selectively modulates many cellular processes [1] . For example, the frequency of [Ca 2+ ] c oscillations can influence gene expression [54, 55] and modulate the activity of Ca 2+ -sensitive enzymes, such as protein kinase C [56] , calmodulin kinase II [57] and mitochondrial dehydrogenases [58] . We therefore propose an important role for physiological modulators of plasma membrane Ca 2+ fluxes, such as natriuretic peptides and miniglucagon, in controlling the frequency of oscillatory [Ca 2+ ] c signalling and thus, in turn, in modulating downstream cellular processes.
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